Oberland Capital Management
Overview
Oberland Capital Management is a private investment firm that provides structured financing solutions, including royalty monetizations and asset-backed credit facilities, to companies across the global healthcare industry.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Humacyte | May 2023 | Debt | Lead |
| Primmune Therapeutics | Jan 2026 | Series B | Co-investor |
| ImmunityBio | Mar 2026 | Post-IPO Financing | Lead |
| NorthStar Medical Radioisotopes, LLC | Apr 2019 | Debt | Lead |
Key People
James James
Managing Director, Business Development and Investor Relations
Cecilia Gonzalo
Partner
Sarah Drew Siber
Partner
William Clifford
Partner
Sean Fillion
Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Oberland Capital Management based?
Oberland Capital Management is headquartered in New York City, New York, United States.
When was Oberland Capital Management founded?
Oberland Capital Management was founded in 2013.
How many portfolio companies does Oberland Capital Management have?
Oberland Capital Management has 4 portfolio companies in Caplight's dataset.
What are some companies in Oberland Capital Management's portfolio?
Portfolio companies visible on Caplight include Humacyte, Primmune Therapeutics, ImmunityBio, NorthStar Medical Radioisotopes, LLC.
What was Oberland Capital Management's most recent investment shown here?
Oberland Capital Management's most recent investment in this portfolio sample was in ImmunityBio in 2026.
What sectors does Oberland Capital Management focus on?
Oberland Capital Management focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Oberland Capital Management focus on?
Oberland Capital Management typically invests at the MultiStage stage.
What is Oberland Capital Management's AUM?
Oberland Capital Management's assets under management are estimated between $3.2B and $3.5B.